Navigation Links
Systemic Lupus Erythematosus Therapeutics (SLE) - Pipeline Assessment and Market Forecasts to 2018
Date:10/19/2011

Systemic Lupus Erythematosus Therapeutics Market, Germany, Market Forecast ($m),2010-2018 24

Table 13: Systemic Lupus Erythematosus Therapeutics Market, Italy, Revenue ($m), 2005-2010 25

Table 14: Systemic Lupus Erythematosus Therapeutics Market, Italy, Market Forecast ($m), 2010-2018 26

Table 15: Systemic Lupus Erythematosus Therapeutics Market, Spain, Revenue ($m), 2005-2010 28

Table 16: Systemic Lupus Erythematosus Therapeutics Market, Spain, Market Forecast ($m), 2010-2018 29

Table 17: Systemic Lupus Erythematosus Therapeutics Market, Japan, Revenue ($m), 2005-2010 30

Table 18: Systemic Lupus Erythematosus Therapeutics Market, Japan, Market Forecast ($m), 2010-2018 31

Table 19: Efficacy Results of Benlysta Versus Placebo 35

Table 20: Systemic Lupus Erythematosus Therapeutics - Phase III Pipeline, 2011 38

Table 21: Systemic Lupus Erythematosus Therapeutics - Phase II Pipeline, 2011 39

Table 22: Systemic Lupus Erythematosus Therapeutics - Phase I/II Pipeline, 2011 39

Table 23: Systemic Lupus Erythematosus Therapeutics - Phase I Pipeline, 2011 39

Table 24: Systemic Lupus Erythematosus Therapeutics - Preclinical Pipeline, 2011 40

Table 25: Systemic Lupus Erythematosus Therapeutics - Discovery Pipeline, 2011 40

Table 26: Systemic Lupus Erythematosus Therapeutics - Other Promising Mechanisms of Actions 42

Table 27: Systemic Lupus Erythematosus Therapeutics - Promising Drugs in Clinical Development 45

Table 28: Efficacy of Epratuzumab 47

Table 29: Disease Severity at Baseline 47

Table 30: Severe (BILAG A) AdverseEffects of Epratuzumab 48

Table 31: Systemic Lupus Erythematosus Therapeutics - Clinical Mapping by Region/Country, 2011 50

Table 32: Systemic Lupus Erythematosus Therapeutics - Clinical Mapping by Phase, 2011 51

Table 33: Systemic Lupus Erythematosus Therapeutics - Clinical Mapping by Trial Status, 2011 52

Ta
'/>"/>

SOURCE Reportlinker
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10

Related biology technology :

1. deCODE Announces Agreement With Pfizer to Search for Variants in the Human Genome That Confer Risk of Systemic Lupus Erythematosis
2. Pevions Therapeutic Candida Vaccine Shows Robust Systemic and Mucosal Immunogenicity, While Epidemiological Survey Confirms Excellent Market Potential
3. Sangamo BioSciences Announces Data Presentation of First In Vivo Demonstration of ZFN-mediated Gene Correction Via Systemic Delivery at American Society for Hematology Meeting
4. Biologic Agents Will Drive the Systemic Lupus Erythematosus Drug Market to More Than Quadruple to Nearly $2 Billion in 2018
5. Human Genome Sciences to Host July 20 Conference Call to Discuss Top-Line Phase 3 Results for Benlysta(TM) (Formerly Lymphostat-B(R)) in Systemic Lupus Erythematosus
6. Human Genome Sciences Reports Positive Long-Term Data for BENLYSTA(TM) (Formerly LymphoStat-B(R)) in Patients With Active Systemic Lupus Erythematosus
7. Trubion Pharmaceuticals, Inc. Announces Initiation of Phase 1 Study of SBI-087 for the Treatment of Systemic Lupus Erythematosus (SLE)
8. Anacor Achieves Milestone from GSK for Boron-Based Systemic Antibacterial Product Candidate
9. Lupus Research Institute: Benlysta(TM) Trial Results in an Historic Research Breakthrough and Victory for People With Lupus
10. Promise of a New Lupus Treatment Is a Groundbreaking Achievement
11. Influenza Vaccines Therapeutics - Pipeline Assessment and Market Forecasts to 2018
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/22/2014)... Dec. 22, 2014  ( www.competitivehealth.com ) — Competitive ... medical bill review and advocacy service, has signed an ... WellCard Savings discount health services marketplace. 63% ... more than they expected to pay. As part of ... costs, WellCard Savings is pleased to offer medical bill ...
(Date:12/22/2014)... 22, 2014 Fertility Associates of Memphis ... Bank USA , a network of more than 20 ... partnership, patients have fast access to a national pool ... IVF . Fertility Associates of Memphis is the only ... treatment option. , Dr. William Kutteh , director ...
(Date:12/19/2014)... BioPlus Specialty Pharmacy (BioPlus), one ... of Nick Maroulis, Pharm.D. to the newly created position ... In this position, Dr. Maroulis will continue to manage ... of our multi-site pharmacies as the company expands. Dr. ... that time he has served in many different capacities ...
(Date:12/19/2014)... Dec. 19, 2014 Bina Technologies, Inc. (Bina, ... that they have been acquired by Roche (SIX: RO, ... privately held company that provides a big data platform ... (NGS) data for the academic and translational research markets. ... and will continue to focus on development of their ...
Breaking Biology Technology:WellCard Savings Announces CoPatient Medical Bill Review Service for Members 2Fertility Associates of Memphis Announces Partnership with Donor Egg Bank USA 2Fertility Associates of Memphis Announces Partnership with Donor Egg Bank USA 3BioPlus Specialty Pharmacy Promotes Dr. Nick Maroulis to Vice President of Specialty Pharmacy Services 2Bina Technologies is acquired by Roche. 2Bina Technologies is acquired by Roche. 3
... , , HOPKINTON, Mass., July 30 ... reported that for the second quarter of 2009 revenues were $32.1 ... Divestitures and foreign currency translation negatively impacted comparative revenues by ... The Company narrowed its net loss to $4.1 million ($0.08 per ...
... TOKYO, July 30 With a business plan to launch ... subsidiary of,the Zydus group, one of India,s leading integrated pharma ... big boost to its operations,in the Japanese generic market which ... estimated at $ 60 bn the generic market is only,about ...
... PLEASANTON, Calif., FRAMINGHAM, Mass. and SYDNEY, ... a world leader in device-based mechanical circulatory support therapies to ... (Nasdaq: HTWR ; ASX: HIN), which develops and ... States Federal Trade Commission ("FTC") has informed them that the ...
Cached Biology Technology:Caliper Life Sciences Reports Second Quarter 2009 Results 2Caliper Life Sciences Reports Second Quarter 2009 Results 3Caliper Life Sciences Reports Second Quarter 2009 Results 4Caliper Life Sciences Reports Second Quarter 2009 Results 5Caliper Life Sciences Reports Second Quarter 2009 Results 6Caliper Life Sciences Reports Second Quarter 2009 Results 7Caliper Life Sciences Reports Second Quarter 2009 Results 8Caliper Life Sciences Reports Second Quarter 2009 Results 9Caliper Life Sciences Reports Second Quarter 2009 Results 10"Over the Next 2-3 Years We Will Leverage Developmental Capabilities and Explore In-licensing and a Co-development Model to Consolidate Our Presence in Japan" - Dr. Kailash Sharma, President, Japan Operations, Zydus Cadila 2U.S. Federal Trade Commission to Challenge Thoratec's Proposed Acquisition of HeartWare International 2U.S. Federal Trade Commission to Challenge Thoratec's Proposed Acquisition of HeartWare International 3U.S. Federal Trade Commission to Challenge Thoratec's Proposed Acquisition of HeartWare International 4
(Date:12/22/2014)... 22, 2014 Research and Markets ... addition of the "The Global Watermarking ... offering. http://photos.prnewswire.com/prnh/20130307/600769 ... overview of the global digital media watermarking ... and monitor piracy by securely and invisibly ...
(Date:12/19/2014)... , Dec. 18, 2014   LaunchKey , ... for the post-password and Internet of Things era, today ... funding. The venture round was led by Metamorphic Ventures ... Rimrock Venture Partners, VegasTechFund, and others.  LaunchKey has raised ... funding to expand its team and bring LaunchKey to ...
(Date:12/17/2014)... Dec. 16, 2014 Research and Markets ... of the "Global Chemical Sensor Market 2015-2019" ... http://photos.prnewswire.com/prnh/20130307/600769 One major ... demand for medical sensors in biomedical applications. Chemical ... quick and correct diagnosis during surgical procedures. The ...
Breaking Biology News(10 mins):The Global Watermarking and Fingerprinting Markets 2LaunchKey Raises $3 Million in Additional Funding Led by Metamorphic Ventures 2LaunchKey Raises $3 Million in Additional Funding Led by Metamorphic Ventures 3Global Chemical Sensor Market 2015-2019: Key Vendors are Abbott Laboratories, Bayer, Hoffmann La-Roche, Johnson & Johnson, NGK Spark Plugs and Robert Bosch 2
... Respiratory syncytial virus (RSV) infection is a widespread infant illness ... but may be curable by the development of this new ... and The University of Queensland's Faculty of Biological and Chemical ... cost millions of dollars a year in health care in ...
... by just 1.2 percent, yet there is a considerable difference ... A new study showed that a certain form of neuropsin, ... is expressed only in the central nervous systems of humans ... The study, which also demonstrated the molecular mechanism that creates ...
... immune system component that is a primary cause of ... rheumatoid arthritis actually protects bone in the oral cavity ... periodontal disease in humans, research at the University at ... only in the past 18 months to be a ...
Cached Biology News:UQ research heralds vaccine technology breakthrough 2Gene mutation linked to cognition is found only in humans 2Molecule that destroys bone also protects it, new research shows 2Molecule that destroys bone also protects it, new research shows 3
Human Cell Line Slides...
... Each Signet Level 2 Detection ... the avidin-biotin chemical bonding principle and ... to provide sensitivity, specificity and reliablility. ... immunostaining in both manual and automated ...
Mouse monoclonal [3576] to Yellow Fever Virus ( Abpromise for all tested applications). Antigen: Tissue / cell preparation...
... Level 2 Detection System combines the ... bonding principle and Signets unique formulation ... specificity and reliablility. Signet reagents will ... manual and automated protocols. ,Signets ...
Biology Products: